We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 3

1.
Figure 2

Figure 2. From: Alpha1-Antitrypsin Deficiency Carriers, Tobacco Smoke, Chronic Obstructive Pulmonary Disease, and Lung Cancer Risk.

Adjusted odds ratio of risk factors by smoking intensity. α1ATD indicates alpha1-antitrypsin deficiency; COPD, chronic obstructive pulmonary disease; and ETS, environmental tobacco smoke. Error bars indicate 95% confidence intervals.

Ping Yang, et al. Arch Intern Med. ;168(10):1097-1103.
2.
Figure 1

Figure 1. From: Alpha1-Antitrypsin Deficiency Carriers, Tobacco Smoke, Chronic Obstructive Pulmonary Disease, and Lung Cancer Risk.

Isoelectric focusing test for alpha1-antitrypsin allele types. A, Selected Pi variants as revealed by isoelectric focusing (polyacrylamide gel, anode at the top and cathode at the bottom) (nomenclature of allele names from Cox et al18). B, Selected Pi variants observed in human plasma using isoelectric focusing (polyacrylamide gel, anode is at the top) from Mayo Clinic Immunopathology Protein Laboratory.

Ping Yang, et al. Arch Intern Med. ;168(10):1097-1103.
3.
Figure 3

Figure 3. From: Alpha1-Antitrypsin Deficiency Carriers, Tobacco Smoke, Chronic Obstructive Pulmonary Disease, and Lung Cancer Risk.

Adjusted odds ratios (95% confidence intervals) of risk factors by cell types of lung cancer. α1ATD indicates alpha1-antitrypsin deficiency; COPD, chronic obstructive pulmonary disease; AD, adenocarcinoma; BAC, bronchioalveolar carcinoma; SQCLC, squamous cell lung cancer; and SCLC, small cell lung cancer.

Ping Yang, et al. Arch Intern Med. ;168(10):1097-1103.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk